0000899243-22-015764.txt : 20220427
0000899243-22-015764.hdr.sgml : 20220427
20220427160535
ACCESSION NUMBER: 0000899243-22-015764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220426
FILED AS OF DATE: 20220427
DATE AS OF CHANGE: 20220427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Golumbeski George
CENTRAL INDEX KEY: 0001586660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 22859508
MAIL ADDRESS:
STREET 1: C/O CELGENE CORP.
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 512-900-4690
MAIL ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-26
0
0001680367
Shattuck Labs, Inc.
STTK
0001586660
Golumbeski George
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
1
0
0
0
Common Stock
2022-04-26
4
P
0
28330
3.63
A
54613
D
This transaction was executed in multiple trades at prices ranging from $3.505 to $3.78. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Erin Ator Thomson, Attorney-in-Fact for George Golumbeski
2022-04-27